The global cell therapy packaging market size is anticipated to reach USD 1,219.9 billion by 2033, growing at a CAGR of 12.0% from 2026 to 2033, according to a new report by Grand View Research, Inc. The increasing commercialization of cell and gene therapies is driving demand for specialized packaging solutions that maintain cell viability, sterility, and temperature integrity throughout storage and transportation. The growing number of cell therapy clinical trials and regulatory approvals is further supporting market expansion. In recent years, both autologous and allogeneic therapies have advanced towards commercialization. Considering evolving market dynamics, manufacturers are actively validating advanced packaging systems, ensuring chain-of-identity, chain-of-custody, and product protection during distribution across countries worldwide.
Rising demand for cryogenic and ultra-cold chain logistics is also contributing to market growth. Most cell therapies require transportation and storage at extremely low temperatures, prompting the adoption of advanced cryogenic containers, insulated shippers, and temperature-monitoring packaging technologies to minimize the risk of sample degradation.
Stringent regulations govern the transportation and logistics of cell therapy. The trend of outsourcing packaging and logistics to specialized contract services is also on the rise, driving the demand for better cell therapy packaging alternatives. Cell therapy developers are partnering with packaging and cold-chain experts to improve regulatory compliance, reduce operational complexity, and enhance supply chain reliability for sensitive biological products.
Advancements in smart packaging, real-time tracking, and temperature-monitoring technologies are further strengthening the market. Manufacturers are integrating real-time tracking systems and validated packaging platforms to ensure product traceability, maintain quality standards, and support personalized cell therapy supply chains across international markets.
Request a free sample copy or view report summary: Cell Therapy Packaging Market Report
North America dominated the cell therapy packaging industry with the largest revenue share of 39.0% in 2025.
Asia Pacific is expected to grow at the fastest CAGR of 12.4% during the forecast period.
By material, the cryogenic plastics segment held the largest market share in 2025, contributing 38.2% of overall revenue, and is anticipated to expand at a CAGR of 12.2% during the forecast period.
By cell therapy type, the CAR-T cell therapy segment led the market in 2025, capturing 35.63% of the total market share.
The stem cell therapy segment is expected to witness strong growth, registering a CAGR of 12.7% from 2026 to 2033 in revenue terms.
By packaging type, the primary packaging segment led the market in 2025, capturing 42.3% of the total revenue share.
The tertiary packaging segment is expected to witness strong growth, registering a CAGR of 12.5% from 2026 to 2033 in terms of revenue.
Grand View Research has segmented the global cell therapy packaging market based on material, cell therapy type, packaging type, and region:
Cell Therapy Packaging Packaging Type Outlook (Revenue, USD Million, 2021 - 2033)
Primary Packaging
Secondary Packaging
Tertiary Packaging
Cell Therapy Packaging Material Outlook (Revenue, USD Million, 2021 - 2033)
Cryogenic Plastics
Single-use Polymer Systems
Glass
Paperboard & Corrugated Materials
Metal & Composite Alloys
Cell Therapy Packaging Cell Therapy Type Outlook (Revenue, USD Million, 2021 - 2033)
CAR-T Cell Therapy
Stem Cell Therapy
NK Cell Therapy
Dendritic Cell Therapy
Other Cell Therapies
Cell Therapy Packaging Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Asia Pacific
China
India
Japan
South Korea
Australia
Latin America
Brazil
Argentina
Middle East & Africa
Saudi Arabia
UAE
South Africa
List of Key Players in the Cell Therapy Packaging Market
CSAFE
Cryoport Systems, LLC.
Sartorius AG
BioLife Solutions Inc.
Thermo Fisher Scientific Inc.
ThermoSafe
Catalent, Inc
Cold Chain Technologies
va-Q-tec Thermal Solutions GmbH
Azenta US Inc.
"The quality of research they have done for us has been excellent..."